North Star Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Hold |
1,300
| – | – | 0.01% | 507 |
|
|
2025
Q1 | $88.8K | Hold |
1,300
| – | – | 0.01% | 527 |
|
|
2024
Q4 | $101K | Buy |
1,300
+1,020
| +364% | +$79.3K | 0.01% | 504 |
|
|
2024
Q3 | $18.8K | Sell |
280
-100
| -26% | -$6.7K | ﹤0.01% | 736 |
|
|
2024
Q2 | $43.1K | Buy |
380
+100
| +36% | +$11.3K | ﹤0.01% | 617 |
|
|
2024
Q1 | $38.8K | Hold |
280
| – | – | ﹤0.01% | 649 |
|
|
2023
Q4 | $34.7K | Sell |
280
-15
| -5% | -$1.86K | ﹤0.01% | 646 |
|
|
2023
Q3 | $27.5K | Hold |
295
| – | – | ﹤0.01% | 686 |
|
|
2023
Q2 | $37.9K | Hold |
295
| – | – | ﹤0.01% | 652 |
|
|
2023
Q1 | $34.3K | Hold |
295
| – | – | ﹤0.01% | 674 |
|
|
2022
Q4 | $33.4K | Buy |
295
+15
| +5% | +$1.7K | ﹤0.01% | 663 |
|
|
2022
Q3 | $23K | Hold |
280
| – | – | ﹤0.01% | 672 |
|
|
2022
Q2 | $21K | Hold |
280
| – | – | ﹤0.01% | 701 |
|
|
2022
Q1 | $36K | Hold |
280
| – | – | ﹤0.01% | 643 |
|
|
2021
Q4 | $38K | Hold |
280
| – | – | ﹤0.01% | 670 |
|
|
2021
Q3 | $38K | Hold |
280
| – | – | ﹤0.01% | 640 |
|
|
2021
Q2 | $30K | Hold |
280
| – | – | ﹤0.01% | 678 |
|
|
2021
Q1 | $25K | Hold |
280
| – | – | ﹤0.01% | 667 |
|
|
2020
Q4 | $26K | Hold |
280
| – | – | ﹤0.01% | 640 |
|
|
2020
Q3 | $29K | Hold |
280
| – | – | ﹤0.01% | 603 |
|
|
2020
Q2 | $28K | Hold |
280
| – | – | ﹤0.01% | 578 |
|
|
2020
Q1 | $19K | Hold |
280
| – | – | ﹤0.01% | 638 |
|
|
2019
Q4 | $15K | Buy |
+280
| New | +$15K | ﹤0.01% | 751 |
|